Search

Vaxcyte Inc

Open

SectorHealthcare

60.85 -0.56

Overview

Share price change

24h

Current

Min

60.66

Max

61.28

Key metrics

By Trading Economics

Income

-284M

-605M

EPS

-1.97

Employees

507

EBITDA

22M

-292M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+86.94% upside

Dividends

By Acuity

Next Earnings

2 lis 2026

Market Stats

By TradingEconomics

Market Cap

1.3B

9B

Previous open

61.41

Previous close

60.85

News Sentiment

By Acuity

50%

50%

132 / 339 Ranking in Healthcare

Vaxcyte Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

4 wrz 2026, 20:08 UTC

News

Vaxcyte Inc. appointed new executives and accelerated its timeline for trial data, with shares trading lower during Friday's session.

3 wrz 2026, 20:14 UTC

News

Vaxcyte shares are lower in after-market hours following leadership appointments and narrowed guidance for VAX-31 topline data, now expected by October 2026.

2 wrz 2026, 20:08 UTC

Vaxcyte Inc is gaining today, driven by strong performance in the Biotechnology sub-sector, despite earlier pulling back from a session high.

1 wrz 2026, 20:09 UTC

Vaxcyte Inc shares are lower today, influenced by a broad market decline amid rising oil prices and increasing Treasury yields. No specific company news was identified.

31 sie 2026, 19:16 UTC

Vaxcyte Inc is trading higher since Friday's close, reflecting a positive performance backdrop. Shares remain above their 20-day moving average.

28 sie 2026, 20:07 UTC

Vaxcyte Inc shares are lower amid a broader market downturn. Rising U.S. Treasury yields and inflation concerns contribute to the decline in equity prices.

25 sie 2026, 20:07 UTC

Vaxcyte Inc. shares are lower today, having peaked earlier before drifting downwards. The broader market sees a drop in oil prices and Treasury yields.

24 sie 2026, 19:46 UTC

Vaxcyte Inc's shares are lower amid rising oil prices and geopolitical tensions. No specific company news was identified to explain the decline.

21 sie 2026, 21:01 UTC

Vaxcyte Inc is trading higher in after-market hours, maintaining a notable increase since Friday's close, amid positive market sentiment.

20 sie 2026, 23:46 UTC

Vaxcyte Inc shares are lower in after-market hours, with no specific news identified. Broader market declines may be affecting investor sentiment in biotechnology.

19 sie 2026, 20:02 UTC

Correlated Moves

Vaxcyte Inc. shares are higher during Wednesday's session, continuing a positive trend with strong investor interest. The stock aligns with gains in the biotechnology sector.

14 sie 2026, 20:06 UTC

Vaxcyte Inc's shares are lower today, breaking a trend of higher closes. This decline aligns with weaker-than-expected U.S. retail sales data for July.

12 sie 2026, 19:46 UTC

Vaxcyte Inc shares are higher today, supported by broader market gains following positive sentiment from the recent inflation report. The stock remains above its 20-day moving average.

11 sie 2026, 23:11 UTC

Vaxcyte Inc shares are higher in after-market trading, reflecting positive momentum despite no specific news driving the price action.

10 sie 2026, 19:56 UTC

Vaxcyte Inc shares are higher, continuing gains since Friday's close, reaching a peak earlier in the session. No specific news was identified for the move.

7 sie 2026, 21:01 UTC

Vaxcyte Inc shares are lower in after-market hours, continuing a weak trading session without any specific news to explain the decline.

6 sie 2026, 20:03 UTC

News

Vaxcyte reports a net loss of $284.3 million for Q2. Shares are trading higher as the company anticipates key Phase 3 trial data in 2027.

5 sie 2026, 19:16 UTC

Vaxcyte Inc. shares are higher today, aligning with broader market trends, despite no specific news identified. The stock remains near its one-month range low.

4 sie 2026, 20:21 UTC

Vaxcyte Inc. shares are lower in after-market trading, remaining flat since Tuesday's close and positioned below its 20-day moving average.

3 sie 2026, 19:46 UTC

Vaxcyte Inc's shares are lower today, continuing a decline since Friday. The stock is trading near the lower end of its one-month range.

31 lip 2026, 19:56 UTC

Correlated Moves

Shares lower amid broader sector sentiment; SPDR S&P Biotech ETF declines.

30 lip 2026, 18:52 UTC

Vaxcyte Inc's shares are higher today amid strong buying activity, reaching an intraday high but remain below the 20-day moving average.

29 lip 2026, 18:23 UTC

Vaxcyte Inc is lower in Wednesday's session, breaking a trend of higher daily closes. No specific news was identified to explain the decline.

28 lip 2026, 18:46 UTC

Vaxcyte Inc. shares are trading lower amid broader market trends and volatility, remaining below the 20-day moving average as bond yields decline.

27 lip 2026, 19:46 UTC

Vaxcyte Inc shares are trading higher today, despite earlier declines and without specific company news. Broader market volatility is influenced by falling crude oil prices.

23 lip 2026, 19:16 UTC

Vaxcyte Inc shares are lower today amid a broader decline in tech stocks following earnings reports from Alphabet and Tesla. No specific news was identified.

21 lip 2026, 18:26 UTC

Vaxcyte Inc is trading higher today, continuing its advance since Monday's close. This movement occurs despite concerns over rising treasury yields and geopolitical tensions.

Peer Comparison

Price change

Vaxcyte Inc Forecast

Price Target

By TipRanks

86.94% upside

12 Months Forecast

Average 114.33 USD  86.94%

High 163 USD

Low 75 USD

Based on 6 Wall Street analysts offering 12 month price targets forVaxcyte Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Sentiment

By Acuity

132 / 339 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Vaxcyte Inc

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
help-icon Live chat